Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008

Vaccine

Volumn 30, Issue 4, 2012, Pages 813-819

  Duderstadt, Susan K ^a,d   Rose, Charles E ^b   Real, Theresa M ^a,d   Sabatier, Jennifer F ^c   Stewart, Brock ^a,e   Ma, Guihua ^a,d   Yerubandi, Uma D ^a,d   Eick, Angelia A ^f   Tokars, Jerome I ^a   McNeil, Michael M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Logistics Health Incorporated   (United States)

^e SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^f U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

Author keywords

Adult vaccination; Type 1 diabetes mellitus; Vaccine safety

Indexed keywords

ANTHRAX VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; SMALLPOX VACCINE; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ADOLESCENT; ADULT; ARMY; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SOLDIER; VACCINATION;

ADOLESCENT; ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; HUMANS; MALE; MILITARY PERSONNEL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES; VACCINATION; VACCINES; YOUNG ADULT;

EID: 84855340728     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.087     Document Type: Article

References (52)

1. Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. Pediatr Infect Dis J 1999, 18(3):217-222. The Institute for Vaccine Safety Diabetes Workshop Panel.
2. Classen D.C., Classen J.B. Immunisation and type 1 diabetes mellitus: is there a link?. Drug Saf 1999, 21(5):423-425.
3. Chen R.T., Pless R., DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001, 16(3):309-318.
4. Safety: Epidemiologic Studies. The Anthrax Vaccine. Is it Safe? Does it work? 2002, National Academy Press, Washington, DC, pp. 91-131. L.M. Joellenbeck, L.L. Zwanziger, J.S. Durch, B.L. Strom (Eds.).
5. Rehme P.A., Williams R., Grabenstein J. Ambulatory medical visits among anthrax-vaccinated and unvaccinated personnel after return from southwest Asia. Mil Med 2002, 167(3):205-210.
6. Lange J.L., Lesikar S.E., Rubertone M.V., Brundage J.F. Comprehensive systematic surveillance for adverse events of anthrax vaccine adsorbed US Armed Forces, 1998-2000. Vaccine 2003, 21(15):1620-1628.
7. AMSA 1001c Surveillance of adverse effects of anthrax vaccine adsorbed: results of analyses requested by the Institute of Medicine Committee to Assess the Safety and Efficacy of the Anthrax Vaccine. Washington, D.C.: Army Medical Surveillance Activity, U.S., Army Center for Health Promotion and Preventive Medicine. The Anthrax Vaccine. Is it Safe? Does it work? 2002, 91-131. National Academy Press, Washington, DC.
8. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20(7):1183-1197.
9. Department of Health and Human Services Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Available from [accessed 10.09.10]. http://www.cdc.gov/diabetes/pubs/factsheet07.htm.
10. United States Department of Defense. Medical Standards for Appointment, Enlistment, or Induction in the Military Services. Re-issue of DoD Directive 6130.3 (2010). Available from [accessed 10.09.10]. http://www.dtic.mil/whs/directives/corres/pdf/613003p.pdf.
11. Greenburg D., Haverkos H.W., Vigersky R. Diabetes mellitus, active component, U.S. Armed Forces, 1997-2007. MSMR 2009, 16(2):7-9.
12. Wilson C., Susan L., Lynch A., Saria R., Peterson D. Patients with diagnosed diabetes mellitus can be accurately identified in an Indian Health Service patient registration database. Public Health Rep 2001, 116(1):45-50.
13. Blom L., Nyström L., Dahlquist G. The Swedish childhood diabetes study. Diabetologia 1991, 34(3):173-181.
14. Karavanaki K., Tsoka E., Karayianni C., Petrou V., Pippidou E., Brisimitzi M., et al. Prevalence of allergic symptoms among children with diabetes mellitus type 1 of different socioeconomic status. Pediatr Diabetes 2008, 9(4 Pt 2):407-416.
15. Incidence of diabetes in youth in the United States. JAMA 2007, 297(24):2716-2724. Writing Group for the SEARCH for Diabetes in Youth Study Group.
16. Poston W.S., Haddock C.K., Peterson A.L., Vander Weg M.W., Klesges R.C., Pinkston M.M., et al. Comparison of weight status among two cohorts of US Air Force Recruits. Prev Med 2005, 40(5):602-609.
17. Rhodes E.T., Laffel L.M., Gonzalez T.V., Ludwig D.S. Accuracy of administrative coding for type 2 diabetes in children, adolescents and young adults. Diabetes Care 2007, 30(1):141-143.
18. Famoye F. Restricted generalized Poisson regression model. Commun Stat Theory Methods 1993, 22(5):1335-1354.
19. Rose C.E., Martin S.W., Wannemuehler K.A., Plikaytis B.D. On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data. J Biopharm Stat 2006, 16(4):463-481.
20. Whitaker H.J., Farrington C.P., Spiessens B., Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006, 25(10):1768-1797.
21. Hviid A., Stellfeld M., Wohlfahrt J., Melbye M. Childhood vaccination and type 1 diabetes. N Engl J Med 2004, 350(14):1398-1404.
22. Karvonen M., Cepaitis Z., Tuomilehto J. Association between type I diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ 1999, 318(7192):1169-1172.
23. DeStefano F., Mullooly J.P., Okoro C.A., Chen R.T., Marcy S.M., Ward J.I., et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001, 108(6):e112. Available at, [accessed 10.09.10]. http://www.pediatrics.org/cgi/content/full/108/6/e112.
24. Infections and vaccinations as risk factors for childhood type 1 (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. Diabetologia 2000, 43(1):47-53. EURODIAB Substudy 2 Study Group.
25. Altobelli E., Petrocelli R., Verotti A., Valenti M. Infections and risk of type I diabetes in childhood: a population-based case-control study. Eur J Epidemiol 2003, 18(5):425-430.
26. Montgomery S.M., Ehlin A.G., Ekbom A., Wakefield A.J. Pertussis infection in childhood and subsequent type 1 diabetes mellitus. Diabet Med 2002, 19(12):986-993.
27. Van der Werf N., Kroese F.G., Rozing J., Hillebrands J.L. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007, 23(3):169-183.
28. Hyöty H., Hiltunen M., Reunanen A., Leinikki P., Vesikari T., Lounamaa R., et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland: Childhood Diabetes in Finland Study Group. Diabetologia 1993, 36(12):1303-1308.
29. Hummel M., Ziegler A.G. Vaccines and the appearance of islet cell antibodies in the offspring of diabetic parents: results from the BABY-DIAB study. Diabetes Care 1996, 19(12):1456-1457.
30. Dahlquist G., Gothefors L. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG vaccination. Diabetologica 1995, 38(7):873-874.
31. Classen J.B. Clustering of cases of IDDM 2 to 4 years after hepatitis B immunization is consistent with clustering after infections and progression to IDDM in autoantibody positive individuals. Open Pediatric Med J 2008, 2:1-6. Available at, [accessed 10.09.10]. http://www.vaccines.net/1TOPEDJ.pdf.
32. Classen J.B. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996, 24(3):137-145.
33. Classen J.B. Risk of vaccine induced diabetes in children with a family history of type 1 diabetes. Open Pediatric Med J 2008, 2:7-10. Available at, [accessed 10.09.10]. http://www.vaccines.net/7TOPEDJ.pdf.
34. Hiltunen M., Lönnrot M., Hyöty H. Immunisation and type 1 diabetes mellitus, is there a link?. Drug Saf 1999, 20(3):207-212.
35. Verstraeten T., DeStefano F., Chen R.T., Miller E. Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines. Exp Rev Vaccines 2003, 2(1):21-29.
36. Davila J.C., Payne D.C., Zhang Y., Rose C.E., Aranas A., Hill A.N., et al. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004. Vaccine 2008, 26(12):1577-1584.
37. Payne D.C., Rose C.E., Aranas A., Zhang Y., Tolentino H., Weston E., et al. Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Pharmacoepidemiol Drug Saf 2007, 16(6):605-611.
38. Diabetes among young American Indians Montana and Wyoming, 2000-2002. MMWR 2003, 52(46):1127-1129. Centers for Disease Control and Prevention.
39. Mullooly J.P., Donahue J.G., DeStefano F., Baggs J., Eriksen E. Predictive value of ICD-9-CM codes used in vaccine safety research. Methods Inf Med. 2008, 47(4):328-335. VSD Data Quality Working Group.
40. Saydah S.H., Geiss L.G., Tierney E., Benjamin S.M., Engelgau M., Brancati F. Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol 2004, 14(7):507-516.
41. Miller D.R., Safford M.M., Pogach L.M. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004, 27(Suppl. 2):B10-B21.
42. Gorham E.D., Barrett-Connor E., Highfill-McRoy R.M., Mohr S.B., Garland C.F., Garland F.C., et al. Incidence of insulin-requiring diabetes in US military. Diabetologia 2009, 52(10):2087-2091.
43. Bogliun G., Beghi E. Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barré syndrome. Neurol Sci 2002, 23(3):113-117. Guillain-Barré Syndrome Registry Study Group.
44. Klein N.P., Ray P., Carpenter D., Hansen J., Lewis E., Fireman B., et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010, 28(4):1062-1068.
45. International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 2003, Ingenix-St Anthony Publishing/Medicode, Salt Lake City. 6th ed. A.C. Hart, C.A. Hopkins (Eds.).
46. Kitabchi A.E., Umpierrez G.E., Murphy M.B., Kreisberg R.A. Hyperglycemic crises in adult patients with diabetes, a consensus statement from the American Diabetes Association. Diabetes Care 2006, 29(12):2739-2748.
47. Ostman J., Lönnberg G., Arnqvist H.J., Blohmé G., Bolinder J., Ekbom Schnell A., et al. Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002. J Intern Med 2008, 263(4):386-394.
48. Kyvik K.O., Nystrom L., Gorus F., Songini M., Oestman J., Castell C., et al. The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 2004, 47(3):377-384.
49. Sorhan T., Gilthorpe M.S. Non-differential misclassification of exposure always leads to an underestimate of risk: an incorrect conclusion. Occup Environ Med 1994, 51(12):839-840.
50. Mohr S.B., Garland C.F., Gorham E.D., Garland F.C. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008, 51(8):1391-1398.
51. Tseng M., Giri V., Bruner D.W., Giovannucci E. Prevalence and correlates of vitamin D status in African American Men. BMC Public Health 2009, 9:191.
52. Zimmet P., Turner R., McCarty D., Rowley M., Mackay I. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care 1999, 22(Suppl. 2):B59-B64.